Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 200 | 153 | 0 | 936 | 869 |
| Cost of Goods | 7,501 | 7,804 | 13 | 503 | 606 |
| Gross Profit | -7,301 | -7,651 | -13 | 434 | 262 |
| Operating Expenses | 23,703 | 22,543 | 19,979 | 12,505 | 10,673 |
| Operating Income | -30,503 | -29,390 | -19,979 | -11,568 | -9,804 |
| Interest Expense | 0 | 0 | 0 | 1,045 | 2,479 |
| Other Income | -1,051 | 13,747 | -3,952 | -217 | 73,142 |
| Pre-tax Income | -31,554 | -15,643 | -23,931 | -12,831 | 60,858 |
| Income Tax | N/A | -2,500 | N/A | N/A | N/A |
| Net Income Continuous | -31,554 | -13,143 | -23,931 | -12,831 | 60,858 |
| Net Income Discontinuous | N/A | 456 | -94 | -49 | 35 |
| Minority Interests | N/A | 24 | 24 | 52 | 221 |
| Net Income | $-31,554 | $-12,711 | $-24,049 | $-12,932 | $60,672 |
| EPS Basic Total Ops | -15.90 | -21.30 | -164.42 | -255.03 | 513.80 |
| EPS Basic Continuous Ops | -15.90 | -22.05 | -163.67 | -255.03 | 513.80 |
| EPS Basic Discontinuous Ops | N/A | 0.75 | -0.60 | -0.98 | 0.25 |
| EPS Diluted Total Ops | -16.80 | -39.00 | -165.62 | -255.03 | 513.80 |
| EPS Diluted Continuous Ops | -16.80 | -39.75 | -164.87 | -255.03 | 513.80 |
| EPS Diluted Discontinuous Ops | N/A | 0.75 | -0.60 | -0.98 | 0.25 |
| EPS Diluted Before Non-Recurring Items | -15.45 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-29,640 | $-28,423 | $-19,821 | $-11,560 | $-8,819 |